Cargando…
Innate Immunity Modulating Impurities and the Immunotoxicity of Nanobiotechnology-Based Drug Products
Innate immunity can be triggered by the presence of microbial antigens and other contaminants inadvertently introduced during the manufacture and purification of bionanopharmaceutical products. Activation of these innate immune responses, including cytokine secretion, complement, and immune cell act...
Autores principales: | Holley, Claire K., Dobrovolskaia, Marina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658779/ https://www.ncbi.nlm.nih.gov/pubmed/34885886 http://dx.doi.org/10.3390/molecules26237308 |
Ejemplares similares
-
An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide
por: Holley, Claire K., et al.
Publicado: (2021) -
Advanced Analgesic Drug Delivery and Nanobiotechnology
por: Stoicea, Nicoleta, et al.
Publicado: (2017) -
DNA-Based Applications in Nanobiotechnology
por: Abu-Salah, Khalid M., et al.
Publicado: (2010) -
Nanobiotechnology
por: Diniz, Susana N., et al.
Publicado: (2013) -
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
por: Giannakou, Christina, et al.
Publicado: (2016)